← Leaderboards
Enrique A Mesri
Weill Medical College Of Cornell Univ
$8,640,930
Attributed
$12,200,481
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–22$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$15,025,625 · 7
By mechanism
R01$8,777,644 · 3
U54$3,238,981 · 2
R44$3,000,000 · 1
R13$9,000 · 1
Top collaborators
- Pascal J. Goldschmidt-Clermont9 shared
- Omar Adrian Coso5 shared
- Fred Volinsky3 shared
- Sabita Roy1 shared
Others in their field
Top investigators on “Acquired Immunodeficiency Syndrome”
- David Heimbrook · Leidos Biomedical Research, Inc.$300,790,583
- George R Seage · Abt Associates, Inc.$244,444,207
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$180,045,219
- Barbara Driver · Westat, Inc.$168,632,670
- Michelle Vargas · Ppd Development Lp$163,846,102
- Judith S. Currier · University Of California Los Angeles$150,146,659
Research focus
Acquired Immunodeficiency SyndromeViralKaposi SarcomaMalignant NeoplasmsTumorigenesisSignal TransductionAffectHuman Herpesvirus 8OncogenicGenesMolecularPathogenesisMediatingCellsBaseHerpesviridaeProgramsVirusPreventSamplingCancer EtiologyResearch PersonnelTherapeutic TargetTumor
Grant awards (42)
Administrative Core$63,333
U54 · FY2022 · CA · contact PI
Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis$61,733
R01 · FY2022 · CA · contact PI
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis$578,253
R01 · FY2021 · CA · contact PI
Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis$452,653
R01 · FY2021 · CA · contact PI
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies$182,631
U54 · FY2021 · CA · contact PI
Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis$38,570
R01 · FY2021 · CA · contact PI
Administrative Core$30,115
U54 · FY2021 · CA · contact PI
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies$569,420
U54 · FY2020 · CA · contact PI
Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis$452,652
R01 · FY2020 · CA · contact PI
Administrative Core$94,904
U54 · FY2020 · CA · contact PI
Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis$59,481
R01 · FY2020 · CA · contact PI
Improved Diagnosis of Kaposi's Sarcoma-Associated Herpesvirus Infection$1,000,000
R44 · FY2019 · AI
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies$671,148
U54 · FY2019 · CA · contact PI
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis$443,506
R01 · FY2019 · CA · contact PI
Administrative Core$82,790
U54 · FY2019 · CA · contact PI
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis$52,215
R01 · FY2019 · CA · contact PI
Improved Diagnosis of Kaposi's Sarcoma-Associated Herpesvirus Infection$1,000,000
R44 · FY2018 · AI
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies$670,069
U54 · FY2018 · CA · contact PI
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis$511,052
R01 · FY2018 · CA · contact PI
Administrative Core$71,423
U54 · FY2018 · CA · contact PI
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis$53,829
R01 · FY2018 · CA · contact PI
Improved Diagnosis of Kaposi's Sarcoma-Associated Herpesvirus Infection$1,000,000
R44 · FY2017 · AI
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies$731,876
U54 · FY2017 · CA · contact PI
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis$457,223
R01 · FY2017 · CA · contact PI
Administrative Core$71,272
U54 · FY2017 · CA · contact PI
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis$30,336
R01 · FY2017 · CA · contact PI
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis$457,223
R01 · FY2016 · CA · contact PI
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis$457,223
R01 · FY2015 · CA · contact PI
18th International Workshop on Kaposi's sarcoma herpesvirus and related agents$9,000
R13 · FY2015 · CA · contact PI
ROLE OF Rac AND REACTIVE OXYGEN SPECIES IN KAPOSI'S SARCOMA VIRAL ONCOGENESIS$406,962
R01 · FY2014 · CA · contact PI
ROLE OF Rac AND REACTIVE OXYGEN SPECIES IN KAPOSI'S SARCOMA VIRAL ONCOGENESIS$395,903
R01 · FY2013 · CA · contact PI
ROLE OF Rac AND REACTIVE OXYGEN SPECIES IN KAPOSI'S SARCOMA VIRAL ONCOGENESIS$437,003
R01 · FY2012 · CA · contact PI
ROLE OF Rac AND REACTIVE OXYGEN SPECIES IN KAPOSI'S SARCOMA VIRAL ONCOGENESIS$438,640
R01 · FY2011 · CA · contact PI
ROLE OF Rac AND REACTIVE OXYGEN SPECIES IN KAPOSI'S SARCOMA VIRAL ONCOGENESIS$460,336
R01 · FY2010 · CA · contact PI
BIOLOGY OF KSHV/HHV8 G PROTEIN COUPLED RECEPTOR$142,992
R01 · FY2009 · CA · contact PI
BIOLOGY OF KSHV/HHV8 G PROTEIN COUPLED RECEPTOR$323,212
R01 · FY2008 · CA · contact PI
BIOLOGY OF KSHV/HHV8 G PROTEIN COUPLED RECEPTOR$323,212
R01 · FY2007 · CA · contact PI
BIOLOGY OF KSHV/HHV8 G PROTEIN COUPLED RECEPTOR$332,865
R01 · FY2006 · CA · contact PI
BIOLOGY OF KSHV/HHV8 G PROTEIN COUPLED RECEPTOR$340,875
R01 · FY2005 · CA
BIOLOGY OF KSHV/HHV8 G PROTEIN COUPLED RECEPTOR$378,000
R01 · FY2004 · CA
BIOLOGY OF HHV8/KSHV G PROTEIN COUPLED RECEPTOR$349,642
R01 · FY2002 · CA
BIOLOGY OF HHV8/KSHV G PROTEIN COUPLED RECEPTOR$342,053
R01 · FY2001 · CA